521 related articles for article (PubMed ID: 35972130)
21. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
Damke E; Tsuzuki JK; Cortez DA; Ferreira IC; Bertoni TA; Batista MR; Donati L; Svidzinski TI; Consolaro ME
BMC Complement Altern Med; 2011 May; 11():35. PubMed ID: 21542936
[TBL] [Abstract][Full Text] [Related]
22. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
[TBL] [Abstract][Full Text] [Related]
23. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
[TBL] [Abstract][Full Text] [Related]
24. Antivirulence activity and in vivo efficacy of a thiazole derivative against candidiasis.
Sá NP; Barros PP; Junqueira JC; Valério AD; Lino CI; Oliveira RB; Rosa CA; Johann S
J Mycol Med; 2021 Jun; 31(2):101134. PubMed ID: 33862540
[TBL] [Abstract][Full Text] [Related]
25. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
[No Abstract] [Full Text] [Related]
26. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
Hacioglu M; Guzel CB; Savage PB; Tan ASB
Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
[TBL] [Abstract][Full Text] [Related]
27. Limosilactobacillus reuteri 29A Cell-Free Supernatant Antibiofilm and Antagonistic Effects in Murine Model of Vulvovaginal Candidiasis.
Boahen A; Chew SY; Neela VK; Than LTL
Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1681-1699. PubMed ID: 36881331
[TBL] [Abstract][Full Text] [Related]
28. In-vitro evaluation of virulence markers and antifungal resistance of clinical Candida albicans strains isolated from Karachi, Pakistan.
Jabeen G; Naz SA; Rangel DEN; Jabeen N; Shafique M; Yasmeen K
Fungal Biol; 2023; 127(7-8):1241-1249. PubMed ID: 37495314
[TBL] [Abstract][Full Text] [Related]
29. Thidiazuron, a phenyl-urea cytokinin, inhibits ergosterol synthesis and attenuates biofilm formation of Candida albicans.
Harikrishnan P; Arayambath B; Jayaraman VK; Ekambaram K; Ahmed EA; Senthilkumar P; Ibrahim HM; Sundaresan A; Thirugnanasambantham K
World J Microbiol Biotechnol; 2022 Sep; 38(12):224. PubMed ID: 36114903
[TBL] [Abstract][Full Text] [Related]
30. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
31. Newly Discovered Antimicrobial Peptide Scyampcin
Zhou Y; Meng X; Chen F; Xiong M; Zhang W; Wang KJ
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0002223. PubMed ID: 37162345
[TBL] [Abstract][Full Text] [Related]
32. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
Nagashima M; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
Mohammadi F; Charkhchian M; Mirzadeh M
BMC Oral Health; 2023 May; 23(1):261. PubMed ID: 37143002
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
35. In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis.
Yassin MT; Mostafa AA; Al-Askar AA
BMC Complement Med Ther; 2020 Jan; 20(1):25. PubMed ID: 32020877
[TBL] [Abstract][Full Text] [Related]
36. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
37. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
De Seta F; Schmidt M; Vu B; Essmann M; Larsen B
J Antimicrob Chemother; 2009 Feb; 63(2):325-36. PubMed ID: 19059942
[TBL] [Abstract][Full Text] [Related]
38. Isobavachalcone exhibits antifungal and antibiofilm effects against
Qian W; Lu J; Gao C; Liu Q; Yao W; Wang T; Wang X; Wang Z
Front Cell Infect Microbiol; 2024; 14():1336773. PubMed ID: 38322671
[TBL] [Abstract][Full Text] [Related]
39. Screening antibiofilm activity of invasive plants growing at the Slope Merapi Mountain, Central Java, against Candida albicans.
Desrini S; Girardot M; Imbert C; Mustofa M; Nuryastuti T
BMC Complement Med Ther; 2023 Jul; 23(1):232. PubMed ID: 37438777
[TBL] [Abstract][Full Text] [Related]
40. Anticandidal Activity of Capsaicin and Its Effect on Ergosterol Biosynthesis and Membrane Integrity of
Behbehani JM; Irshad M; Shreaz S; Karched M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
